BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21836539)

  • 1. Prothrombotic gene polymorphisms: possible contributors to hepatic artery thrombosis after orthotopic liver transplantation.
    Pereboom IT; Adelmeijer J; van der Steege G; van den Berg AP; Lisman T; Porte RJ
    Transplantation; 2011 Sep; 92(5):587-93. PubMed ID: 21836539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and acquired prothrombotic risk factors and sudden hearing loss.
    Capaccio P; Ottaviani F; Cuccarini V; Bottero A; Schindler A; Cesana BM; Censuales S; Pignataro L
    Laryngoscope; 2007 Mar; 117(3):547-51. PubMed ID: 17334320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.
    Dodson PM; Haynes J; Starczynski J; Farmer J; Shigdar S; Fegan G; Johnson RJ; Fegan C
    Eye (Lond); 2003 Aug; 17(6):772-7. PubMed ID: 12928694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of prothrombotic mutations and polymorphisms in children who developed thrombosis in the perioperative period of congenital cardiac surgery.
    Ozbek N; Ataç FB; Yildirim SV; Verdi H; Yazici C; Yilmaz BT; Tokel NK
    Cardiol Young; 2005 Feb; 15(1):19-25. PubMed ID: 15831156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
    Eroglu A; Egin Y; Cam R; Akar N
    Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in clotting factors and inflammatory bowel disease.
    Bernstein CN; Sargent M; Vos HL; Rosendaal FR
    Am J Gastroenterol; 2007 Feb; 102(2):338-43. PubMed ID: 17156138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
    Procare-GEHT Group
    Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.
    Kim RJ; Becker RC
    Am Heart J; 2003 Dec; 146(6):948-57. PubMed ID: 14660985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association of factor V Leiden, prothrombin G20210A, and MTHFR C677T gene polymorphisms with kidney allograft survival: a multicenter study.
    Meyer M; Laux G; Scherer S; Tran TH; Opelz G; Mytilineos J
    Transplantation; 2007 Apr; 83(8):1055-8. PubMed ID: 17452895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.
    Ozmen F; Ozmen MM; Ozalp N; Akar N
    Ulus Travma Acil Cerrahi Derg; 2009 Mar; 15(2):113-9. PubMed ID: 19353312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum and prevalence of prothrombotic single nucleotide polymorphism profiles in the Greek Cypriot population.
    Xenophontos SL; Hadjivassiliou M; Ayrton N; Karagrigoriou A; Pantzaris M; Nicolaides AN; Cariolou MA
    Int Angiol; 2002 Dec; 21(4):322-9. PubMed ID: 12518110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of risk factors in the incidence of hepatic artery thrombosis in a consecutive series of 687 liver transplantations].
    Proposito D; Loinaz Segurola C; Garcia Garcìa I; Jimènez C; Gonzalez Pinto I; Gomez Sanz R; De La Cruz J; Moreno Gonzàlez E
    Ann Ital Chir; 2001; 72(2):187-205. PubMed ID: 11552475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
    Rahimi Z; Nomani H; Mozafari H; Vaisi-Raygani A; Madani H; Malek-Khosravi S; Parsian A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
    Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic artery thrombosis after liver transplantation and genetic factors: prothrombin G20210A polymorphism.
    Mas VR; Fisher RA; Maluf DG; Wilkinson DS; Garrett CT; Ferreira-Gonzalez A
    Transplantation; 2003 Jul; 76(1):247-9. PubMed ID: 12865818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MTHFR C677T, FII G20210A, FV Leiden G1691A, NOS3 intron 4 VNTR, and APOE epsilon4 gene polymorphisms are not associated with spontaneous cervical artery dissection.
    Jara-Prado A; Alonso ME; Martínez Ruano L; Guerrero Camacho J; Leyva A; López M; Gutierrez-Castrellon P; Arauz A
    Int J Stroke; 2010 Apr; 5(2):80-5. PubMed ID: 20446941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
    Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
    Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I
    J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.